Literature DB >> 34904931

Poly C Binding Protein 2 dependent nuclear retention of the utrophin-A mRNA in C2C12 cells.

Gargi Ghosh1, Satyabrata Samui2, Santanu Das3, Vandana Singh4, Doel Pal1, Subhanwita Das1, Jishu Naskar2, Soumya Sinha Roy4, Utpal Basu1.   

Abstract

Upregulation of utrophin, the autosomal homologue of dystrophin, can compensate dystrophin deficiency in Duchenne Muscular Dystrophy (DMD) although the therapeutic success is yet to be achieved. The present study has identified Poly (C) binding protein 2 (PCBP2) as a post-transcriptional suppresser for the expression of utrophin-A, the muscle-specific utrophin isoform. This study confirms nuclear retention of utrophin-A mRNA in C2C12 cells, which is mediated by PCBP2. Further investigation demonstrates PCBP2-dependent nuclear retention of follistatin mRNA as well. Its involvement in nuclear retention of mRNA sheds light on a novel function of PCBP2 that makes utrophin-A mRNA less available in cytosol. PCBP2, therefore, may be a target to de-repress utrophin-A expression in DMD.

Entities:  

Keywords:  DMD; PCBP2; follistatin; nuclear retention; utrophin-A

Mesh:

Substances:

Year:  2021        PMID: 34904931      PMCID: PMC8782177          DOI: 10.1080/15476286.2021.2004683

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  37 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.

Authors:  J M Tinsley; A C Potter; S R Phelps; R Fisher; J I Trickett; K E Davies
Journal:  Nature       Date:  1996-11-28       Impact factor: 49.962

3.  Gene silencing by a DNA vector-based RNAi technology.

Authors:  Guangchao Sui; Yang Shi
Journal:  Methods Mol Biol       Date:  2005

4.  Liposome-mediated RNA transfection should be used with caution.

Authors:  Carine Barreau; Stéphanie Dutertre; Luc Paillard; H Beverley Osborne
Journal:  RNA       Date:  2006-08-18       Impact factor: 4.942

5.  Poly(C)-binding protein interacts with the hepatitis C virus 5' untranslated region.

Authors:  K Sp Ngberg; S Schwartz
Journal:  J Gen Virol       Date:  1999-06       Impact factor: 3.891

6.  Heregulin ameliorates the dystrophic phenotype in mdx mice.

Authors:  Thomas O B Krag; Sasha Bogdanovich; Claus J Jensen; M Dominik Fischer; Jacob Hansen-Schwartz; Elisabeth H Javazon; Alan W Flake; Lars Edvinsson; Tejvir S Khurana
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

7.  Integrating single-cell transcriptomic data across different conditions, technologies, and species.

Authors:  Andrew Butler; Paul Hoffman; Peter Smibert; Efthymia Papalexi; Rahul Satija
Journal:  Nat Biotechnol       Date:  2018-04-02       Impact factor: 54.908

8.  PMO-based let-7c site blocking oligonucleotide (SBO) mediated utrophin upregulation in mdx mice, a therapeutic approach for Duchenne muscular dystrophy (DMD).

Authors:  Kasturi Sengupta; Emanuele Loro; Tejvir S Khurana
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

9.  Cis-Acting Sequence Elements and Upstream Open Reading Frame in Mouse Utrophin-A 5'-UTR Repress Cap-Dependent Translation.

Authors:  Trinath Ghosh; Utpal Basu
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

10.  Identification of therapeutics that target eEF1A2 and upregulate utrophin A translation in dystrophic muscles.

Authors:  Christine Péladeau; Nadine Adam; Lucas M Bronicki; Adèle Coriati; Mohamed Thabet; Hasanen Al-Rewashdy; Jason Vanstone; Alan Mears; Jean-Marc Renaud; Martin Holcik; Bernard J Jasmin
Journal:  Nat Commun       Date:  2020-04-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.